Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
| Actual shortage: | 229 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2786 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TADALAFIL | 10MG | TABLET | Resolved | 2021-06-04 | 2021-08-13 | 140439 |
| APO-GABAPENTIN | 300MG | CAPSULE | Resolved | 2021-07-09 | 2021-08-16 | 142275 |
| APO-TADALAFIL | 20MG | TABLET | Resolved | 2021-07-16 | 2021-08-16 | 142690 |
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2021-08-03 | 2021-08-16 | 143404 |
| APO-AMLODIPINE | 10MG | TABLET | Resolved | 2021-07-23 | 2021-08-23 | 142970 |
| APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2021-02-26 | 2021-08-23 | 134811 |
| APO-SILDENAFIL | 50MG | TABLET | Resolved | 2021-06-04 | 2021-08-23 | 140434 |
| APO-QUETIAPINE | 200MG | TABLET | Resolved | 2021-06-25 | 2021-08-25 | 141543 |
| APO-QUETIAPINE | 100MG | TABLET | Actual shortage | 2021-06-11 | 2021-08-27 | 140785 |
| APO-QUETIAPINE | 200MG | TABLET | Actual shortage | 2021-06-11 | 2021-08-27 | 140788 |
| APO-QUETIAPINE | 25MG | TABLET | Actual shortage | 2021-08-27 | 2021-08-27 | 144776 |
| APO-QUETIAPINE | 300MG | TABLET | Actual shortage | 2021-08-27 | 2021-08-27 | 144779 |
| APO-VARENICLINE | 0.5MG | TABLET | Resolved | 2021-07-05 | 2021-08-30 | 141857 |
| APO-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2021-06-25 | 2021-08-31 | 141518 |
| APO-DILTIAZ CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2021-06-11 | 2021-08-31 | 140775 |
| APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2021-07-16 | 2021-08-31 | 142674 |
| APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2021-07-23 | 2021-08-31 | 142979 |
| APO-NALTREXONE | 50MG | TABLET | Resolved | 2021-08-13 | 2021-08-31 | 144142 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2021-07-16 | 2021-08-31 | 142687 |
| APO-FROVATRIPTAN | 2.5MG | TABLET | Resolved | 2021-07-16 | 2021-09-01 | 142680 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IBUPROFEN CAPLETS | 200MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71112 |
| COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
| APO-NITROGLYCERIN | 0.4MG | METERED-DOSE PUMP | Discontinued | 2019-01-04 | 2019-01-04 | 71189 |
| ACETAMINOPHEN HEADACHE ULTRA RELIEF | 500MG 65MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71192 |
| ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
| APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-01-04 | 2019-01-04 | 71207 |
| ACID REDUCER | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71210 |
| APO-LOSARTAN | 100MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71213 |
| ACETAMINOPHEN TABLETS USP 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71216 |
| ACETAMINOPHEN TABLETS USP 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71219 |
| ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71222 |
| ACETAMINOPHEN CAPLETS 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71225 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |